Here's some things they would spend money on besides the resubmission that may keep them from dragging their feet. If they were worried about the resubmission they wouldn't refile. For once you make sense- yes Si would be in a precarious position if it were rejected again- thanks for highlighting that point. Please stop by regularly and bestow your gifts upon us.Operational Expenses
Wages and Salaries
- Scientists and Researchers
- Laboratory Technicians
- Clinical Staff
- Administrative Staff
- Management and Executives
Office and Administrative Expenses
- Office Rent or Mortgage
- Utilities (Electricity, Water, Internet)
- Office Supplies and Stationery
- Office Equipment (Computers, Printers, Furniture)
- Insurance (Liability, Property, Health)
Laboratory Expenses
- Lab Equipment and Maintenance
- Lab Supplies and Consumables (Chemicals, Reagents)
- Safety Equipment and Compliance Costs
- Equipment Calibration and Servicing
Research and Development (R&D)
- Salaries for R&D Staff
- Research Materials and Supplies
- Software and Licensing Fees
- R&D Facility Rent and Utilities
- Intellectual Property Costs (Patents, Trademarks)
Clinical Trials
- Patient Recruitment and Compensation
- Regulatory Submissions and Approvals
- Clinical Trial Site Costs
- Data Management and Analysis
- Monitoring and Reporting
Regulatory and Compliance
- Regulatory Consultant Fees
- Compliance Training and Audits
- Quality Assurance and Control
External Services
Consultants and Professional Services
- Scientific Consultants
- Regulatory Consultants
- Legal Fees (Patent Attorneys, Corporate Lawyers)
- Financial and Tax Advisors
- Marketing and PR Consultants
Contract Research Organizations (CROs)
- Preclinical Testing Services
- Clinical Trial Management
- Data Analysis and Reporting
Collaborations and Partnerships
- Research Partnerships with Universities
- Joint Ventures with Other Biotech Firms
- Licensing Agreements
Marketing and Sales
Marketing Campaigns
- Advertising (Digital, Print, Conferences)
- Promotional Materials
- Market Research
Sales Expenses Not yet Doc but very soon
- Sales Team Salaries and Commissions
- Travel and Accommodation for Sales Team
- Customer Relationship Management (CRM) Software
Miscellaneous Expenses
Travel and Entertainment
- Business Travel (Flights, Hotels)
- Conference Attendance Fees
- Client Entertainment
Training and Development
- Staff Training Programs
- Workshops and Seminars
- Professional Development Courses
Miscellaneous
- Subscriptions and Memberships (Scientific Journals, Industry Associations)
- Contingency Funds for Unexpected Expenses
Capital Expenditures
Facilities and Infrastructure
- Purchase of Land or Buildings
- Renovation and Construction Costs
- Leasehold Improvements
Major Equipment Purchases
- High-Cost Lab Equipment (e.g., Sequencers, Microscopes)
- IT Infrastructure (Servers, Specialized Software)
Finance and Investments
- Loan Interest and Repayments
- Investor Relations
- Reporting and Communication
- Shareholder Meetings and Presentations
- Burrito's at GYG in the food court
Reg
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast to File BLA for Ryoncil FDA Approval Next Week
Ann: Mesoblast to File BLA for Ryoncil FDA Approval Next Week, page-114
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.5¢ |
Change
0.015(1.56%) |
Mkt cap ! $1.113B |
Open | High | Low | Value | Volume |
97.0¢ | 99.5¢ | 97.0¢ | $2.315M | 2.360M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 119971 | 97.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.0¢ | 24889 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 119971 | 0.975 |
6 | 122008 | 0.970 |
4 | 64464 | 0.965 |
9 | 119098 | 0.960 |
3 | 50000 | 0.955 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 24889 | 9 |
0.995 | 82010 | 7 |
1.000 | 85216 | 10 |
1.005 | 36834 | 2 |
1.010 | 37558 | 3 |
Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online